MARTA KIFLE: Open Payments
NPI 1891402350 · INDEPENDENCE, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$247 in 8 payments from 6 companies in 2025. Trend: 2023 $347 · 2024 $229 · 2025 $247
Food & beverage: $135Education: $111
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 1 | $111 |
| Otsuka America Pharmaceutical, Inc. | 3 | $55 |
| Axsome Therapeutics, Inc. | 1 | $24 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $24 |
| Supernus Pharmaceuticals, Inc. | 1 | $17 |
| ABBVIE INC. | 1 | $16 |
Products named: REXULTI, Auvelity, CAPLYTA, Qelbree, VRAYLAR, ABILIFY ASIMTUFII.
Industry payments across MO — which companies pay providers there.
